T1	intervention 230 267	axillary lymph node dissection (ALND)
T2	control 272 304	axillary radiation therapy (ART)
T3	eligibility 308 371	early breast cancer patients with tumor-positive sentinel nodes
T4	total-participants 674 679	2,000
T5	total-participants 965 970	2,000
T6	outcome 1269 1286	Endocrine therapy
T7	iv-bin-percent 1307 1310	78%
T8	iv-bin-abs 1312 1315	235
T9	intervention-participants 1319 1322	300
T10	cv-bin-percent 1363 1366	76%
T11	cv-bin-abs 1368 1371	203
T12	control-participants 1375 1378	266
T13	iv-bin-percent 1177 1180	58%
T14	iv-bin-abs 1182 1185	175
T15	intervention-participants 1189 1192	300
T16	cv-bin-percent 1198 1201	61%
T17	cv-bin-abs 1203 1206	162
T18	control-participants 1210 1213	266
T19	outcome 1246 1267	received chemotherapy
